- Home
- JBGS vs MLAB Comparison
JBGS vs MLAB Comparison
Compare JBGS & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JBGS | MLAB |
|---|---|---|
| Founded | 2016 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Industrial Machinery/Components |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 823.7M | 719.9M |
| IPO Year | 2017 | 1995 |
Fundamental Metrics
Financial Performance| Metric | JBGS | MLAB |
|---|---|---|
| Price | $10.83 | $142.23 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 3 | 3 |
| Target Price | $12.00 | ★ $117.50 |
| AVG Volume (30 Days) | ★ 866.1K | 99.4K |
| Earning Date | 10-27-2026 | 11-05-2026 |
| Dividend Yield | ★ 6.63% | 0.48% |
| EPS Growth | N/A | ★ 436.11 |
| EPS | N/A | ★ 0.49 |
| Revenue | ★ $498,598,000.00 | N/A |
| Revenue This Year | N/A | $2.14 |
| Revenue Next Year | $2.56 | $6.45 |
| P/E Ratio | ★ N/A | $263.88 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.93 | $66.56 |
| 52 Week High | $21.98 | $138.66 |
Technical Indicators
Market Signals| Indicator | JBGS | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 43.90 | 69.15 |
| Support Level | N/A | $89.77 |
| Resistance Level | $11.55 | N/A |
| Average True Range (ATR) | 0.35 | 5.06 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 54.01 | 93.56 |
Price Performance
Historical ComparisonAbout JBGS JBG SMITH Properties
JBG SMITH Properties is a real estate investment trust based in the United States. It owns, operates, invests in, and develops real estate assets concentrated in amenity-rich, metro-served submarkets in and around Washington, DC. In addition, the company also provides fee-based real estate services to legacy funds through its third-party real estate services business. The operating segments of the company are commercial, multifamily, and third-party real estate services. It generates maximum revenue from the commercial segment.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.